GLUCOSAMINE SUPPLEMENTATION MAY INCREASE RISK FOR DEMENTIA BY 25%
Progression to Dementia: Glucosamine use was associated with a 25% higher likelihood that mild cognitive impairment (MCI) would progress to Alzheimer’s disease or related dementias (ADRD).
Mortality Risk: Among patients already diagnosed with ADRD, glucosamine use was linked to a 25% higher mortality risk over a defined period.